Raez, L. E., Arrieta, O., Chamorro, D. F., Soberanis-Piña, P. D., Corrales, L., Martin, C., . . . Cardona, A. F. (2022). Durvalumab After Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer: Inferior Outcomes and Lack of Health Equity in Hispanic Patients Treated With PACIFIC Protocol (LA1-CLICaP).
Cita Chicago Style (17a ed.)Raez, Luis E., et al. Durvalumab After Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer: Inferior Outcomes and Lack of Health Equity in Hispanic Patients Treated With PACIFIC Protocol (LA1-CLICaP). 2022.
Cita MLA (9a ed.)Raez, Luis E., et al. Durvalumab After Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer: Inferior Outcomes and Lack of Health Equity in Hispanic Patients Treated With PACIFIC Protocol (LA1-CLICaP). 2022.
